MARKET

CYPH

CYPH

Cypherpunk Technologies Inc
NASDAQ
1.720
-0.030
-1.71%
Pre Market: 1.680 -0.04 -2.33% 06:17 11/20 EST
OPEN
1.860
PREV CLOSE
1.750
HIGH
1.920
LOW
1.705
VOLUME
13.08K
TURNOVER
0
52 WEEK HIGH
4.190
52 WEEK LOW
0.4913
MARKET CAP
256.35M
P/E (TTM)
-16.5544
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Financial Names: Cypherpunk Technologies (CYPH) and American Express (AXP)
TipRanks · 2d ago
Cypherpunk Technologies Is Maintained at Overweight by Cantor Fitzgerald
Dow Jones · 3d ago
Cypherpunk Technologies Price Target Raised to $5.00/Share From $4.90 by Cantor Fitzgerald
Dow Jones · 3d ago
Cantor Fitzgerald Maintains Overweight on Cypherpunk Technologies, Raises Price Target to $5
Benzinga · 3d ago
Cypherpunk Technologies Earnings Call Signals Zcash Growth
TipRanks · 3d ago
Cypherpunk (CYPH) Q3 2026 Earnings Call Transcript
The Motley Fool · 3d ago
Leap Therapeutics, Inc. Subsidiary Initiates Strategic Process for Sirexatamab and Reports Third Quarter 2026 Financial Results
NASDAQ · 3d ago
Update: Cypherpunk Technologies Q3 Adj. EPS $0.01 Misses $0.04 Estimate, Sales $9.913M Miss $16.200M Estimate
Benzinga · 3d ago
More
About CYPH
Cypherpunk Technologies Inc., formerly Leap Therapeutics, Inc., is engaged in developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The Company focuses on the development of sirexatamab and FL-501 to treat patients with cancer. Zcash is a privacy-preserving blockchains, launched as a fork of Bitcoin with advanced cryptography that enables selective transparency. Zcash has introduced privacy technology through the use of zero-knowledge proofs (zk-SNARKs), allowing transactions to be verified without revealing sender, receiver, or amount. FL-501 is a potential class antibody designed to neutralize GDF-15 and prevent the binding to its receptor. sirexatamab (DKN-01), is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. Sirexatamab is being developed in patients with esophagogastric, gynecologic, and colorectal cancers.

Webull offers Cypherpunk Technologies Inc stock information, including NASDAQ: CYPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CYPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CYPH stock methods without spending real money on the virtual paper trading platform.